Benjamin Burnett
Stock Analyst at Stifel
(1.57)
# 3,253
Out of 4,876 analysts
68
Total ratings
39.58%
Success rate
-7.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $1.04 | +188.46% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $47.49 | +3.18% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $65.35 | +86.69% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $16.80 | +310.71% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $21.37 | +218.20% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.18 | +289.83% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $7.96 | +622.36% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $4.30 | +18,039.53% | 2 | Sep 10, 2021 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $36.91 | +73.39% | 5 | Apr 1, 2025 | |
| IRON Disc Medicine | Maintains: Buy | $90 → $94 | $54.50 | +72.48% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.38 | +189.86% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.42 | +604.23% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.69 | +1,379.29% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $330 → $360 | $25.76 | +1,297.52% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.54 | +2,858.03% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $1.04
Upside: +188.46%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $47.49
Upside: +3.18%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $65.35
Upside: +86.69%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $16.80
Upside: +310.71%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $21.37
Upside: +218.20%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.18
Upside: +289.83%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $7.96
Upside: +622.36%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $4.30
Upside: +18,039.53%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $36.91
Upside: +73.39%
Disc Medicine
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $54.50
Upside: +72.48%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.38
Upside: +189.86%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.42
Upside: +604.23%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $1.69
Upside: +1,379.29%
Jun 28, 2021
Upgrades: Buy
Price Target: $330 → $360
Current: $25.76
Upside: +1,297.52%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.54
Upside: +2,858.03%